Reveal Pharmaceuticals

Natural Resources · Rare Earth Metals

Facts

as of Nov 18, 2026

Reveal Pharmaceuticals is developing RVP-001, a gadolinium-free, manganese-based general purpose MRI contrast agent in Phase 2 clinical studies with FDA Fast Track designation.

Headquarters
Cambridge, United States
Employees
51-200estimated range
Website
revealpharma.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

10 public grants on record, $15.7M in total.

$15.7MPublic grants10 public grants
Money by yearUSD, rounds and grants
2023$8.1M3 records
2022$290k1 record
2021$2.1M1 record
2020$2.3M2 records
2019$300k1 record
2018$2.5M1 record
2017$210k1 record
Largest rounds and grants
2023
$4.1M
2018
$2.5M
2023
$2.1M
2021
$2.1M
2020
$2M
Sources: funding announcements, grant and company registers

Milestones

Sep 1, 2023
Won a grant $1.9M · CORDIS
Jun 5, 2023
Won a grant $4.1M · CORDIS
Each milestone is dated by its source: registers, filings, the press